Triomab® Advantages

In total, Triomab® compounds have a number of advantages over conventional antibodies.

Triomab® molecules:

• Specifically and simultaneously activate multiple immune defense mechanisms against cancer cells.
• Efficiently induce the elimination of tumor cells by activating accessory cells (as conventional antibodies do) and T cells (as conventional antibodies cannot do). 
• Can trigger a long-term immune response, similar to that conferred by vaccination.
• Are up to 1,000-fold more effective than conventional antibodies.
• Can be produced in comparatively small facilities using a straight-forward process.
• Can easily be adapted to other cancer indications via exchange of the tumor-associated antigen.